Study on the quality of life in patients with post-herpetic neuralgia_West China Medical Journal

Authors：

HUANG Wei , DAI Ruoyi ,  GU Xiaohong

Department of Health Management, Daping Hospital, Research Institute of Surgery, the Third Military Medical University, Chongqing 400042, P. R. China;

Corresponding?author：

GU Xiaohong, Email: 286628359@qq.com

Keywords：

Post-herpetic neuralgia; Quality of life; Influenting factors

DOI：

10.7507/1002-0179.201603153

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the general state, psychologic status and health related quality of life (HRQOL) in patients with post-herpetic neuralgia (PHN), and explore the influencing factors on HRQOL and their major and minor relationship. Methods From August 2014 to August 2015, a questionnaire survey was conducted to patients with PHN. The data of the patients’ general situation was colleted, the psychologic status was assessed by Self-rating Depression Scale (SDS), and the HRQOL of the patients was assessed by 36-item Short Form Survey. One-way ANOVA and stepwise regression analysis were used to analyze the influencing factors of HRQOL. Results A total of 177 questionnaires were issued, and 158 were recovered with a response rate of 89.3%. The average score of HRQOL of the 158 patients was 513.67±119.79, and the average score of SDS was 43.65±11.34. SDS scores showed no depression in 41 patients (25.9%), mild depression in 47 (29.7%), moderate depression in 39 (24.8%), and severe depression in 31 (19.6%). Whether receiving regular treatment, course of PHN, SDS score, physical exercise, sleep time and age were the main influencing factors of HRQOL. Conclusions Most patients with PHN suffer from depressive symptoms with poor HRQOL scores. Receiving early treatment with integrated traditional Chinese and western medicine, strengthening exercise, ensuring adequate sleep and receiving psychological counseling can significantly improve the HRQOL of PHN patients.

Citation： HUANG Wei, DAI Ruoyi, GU Xiaohong. Study on the quality of life in patients with post-herpetic neuralgia. West China Medical Journal, 2017, 32(8): 1203-1207. doi: 10.7507/1002-0179.201603153 Copy

1.	Dong H, Hu Y, Basude ME. Post-herpetic acneiform eruption: report of two cases with dermoscopic observations. Australas J Dermatol, 2015, 56(4): 310-311.
2.	Riopelle J, Kaye AD. Transition from injectable to percutaneous local anesthetic therapy in a patient with post-herpetic neuralgia. Pain Physician, 2016, 19(2): E359-E360.
3.	Ma SM, Ni JX, Li XY, et al. High-frequency repetitive transcranial magnetic stimulation reduces pain in postherpetic neuralgia. Pain Med, 2015, 16(11): 2162-2170.
4.	Sonneveld P, Verelst SG, Lewis P, et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia, 2013, 27(10): 1959-1969.
5.	陳攀, 林辰, 方剛, 等. 壯醫藥線點灸對帶狀皰疹后遺神經痛患者 ERK1/2、JNK 基因表達的影響. 時珍國醫國藥, 2015, 26(7): 1768-1769.
6.	Dias PA, Guimar?es AB, Albuquerque Ade O, et al. Short-term complementary and alternative medicine on quality of life in women with fibromyalgia. J Integr Med, 2016, 14(1): 29-35.
7.	Umegaki Y, Todo N. Psychometric properties of the Japanese CES-D, SDS, and PHQ-9 depression scales in university students. Psychol Assess, 2017, 29(3): 354-359.
8.	莫清蓮, 李美康. 黃瑾明教授綜合療法治療帶狀皰疹后遺神經痛的經驗. 時珍國醫國藥, 2015, 26(1): 220-222.
9.	張鳳仙. 紅光治療帶狀皰疹后遺神經痛的臨床療效觀察. 時珍國醫國藥, 2014, 25(2): 397-398.
10.	Jamali R, Biglari M. The comparison of WHOQOL-BREF with disease specific heath related quality of life questionnaire in irritable bowel syndrome. Acta Med Iran, 2015, 53(11): 717-724.
11.	謝君, 梁東輝, 徐翔, 等. 帶狀皰疹后遺神經痛患者心理狀態對康復的影響. 醫學綜述, 2011, 17(24): 3830-3832.
12.	吉彬. 中西醫結合治療帶狀皰疹后遺神經痛的進展. 中國醫藥指南, 2014, 12(31): 65-66.
13.	謝文軍. 阿昔洛韋與泛昔洛韋治療帶狀皰疹的療效對比. 臨床合理用藥雜志, 2015, 8(18): 58-59.
14.	彭光玲, 李惠. 早期足量抗病毒治療帶狀皰疹臨床療效觀察. 重慶醫科大學學報, 2013, 38(3): 311-314.
15.	帶狀皰疹后神經痛診療共識編寫專家組. 帶狀皰疹后神經痛診療中國專家共識. 中國疼痛醫學雜志, 2016, 22(3): 161-167.

1. Dong H, Hu Y, Basude ME. Post-herpetic acneiform eruption: report of two cases with dermoscopic observations. Australas J Dermatol, 2015, 56(4): 310-311.
2. Riopelle J, Kaye AD. Transition from injectable to percutaneous local anesthetic therapy in a patient with post-herpetic neuralgia. Pain Physician, 2016, 19(2): E359-E360.
3. Ma SM, Ni JX, Li XY, et al. High-frequency repetitive transcranial magnetic stimulation reduces pain in postherpetic neuralgia. Pain Med, 2015, 16(11): 2162-2170.
4. Sonneveld P, Verelst SG, Lewis P, et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia, 2013, 27(10): 1959-1969.
5. 陳攀, 林辰, 方剛, 等. 壯醫藥線點灸對帶狀皰疹后遺神經痛患者 ERK1/2、JNK 基因表達的影響. 時珍國醫國藥, 2015, 26(7): 1768-1769.
6. Dias PA, Guimar?es AB, Albuquerque Ade O, et al. Short-term complementary and alternative medicine on quality of life in women with fibromyalgia. J Integr Med, 2016, 14(1): 29-35.
7. Umegaki Y, Todo N. Psychometric properties of the Japanese CES-D, SDS, and PHQ-9 depression scales in university students. Psychol Assess, 2017, 29(3): 354-359.
8. 莫清蓮, 李美康. 黃瑾明教授綜合療法治療帶狀皰疹后遺神經痛的經驗. 時珍國醫國藥, 2015, 26(1): 220-222.
9. 張鳳仙. 紅光治療帶狀皰疹后遺神經痛的臨床療效觀察. 時珍國醫國藥, 2014, 25(2): 397-398.
10. Jamali R, Biglari M. The comparison of WHOQOL-BREF with disease specific heath related quality of life questionnaire in irritable bowel syndrome. Acta Med Iran, 2015, 53(11): 717-724.
11. 謝君, 梁東輝, 徐翔, 等. 帶狀皰疹后遺神經痛患者心理狀態對康復的影響. 醫學綜述, 2011, 17(24): 3830-3832.
12. 吉彬. 中西醫結合治療帶狀皰疹后遺神經痛的進展. 中國醫藥指南, 2014, 12(31): 65-66.
13. 謝文軍. 阿昔洛韋與泛昔洛韋治療帶狀皰疹的療效對比. 臨床合理用藥雜志, 2015, 8(18): 58-59.
14. 彭光玲, 李惠. 早期足量抗病毒治療帶狀皰疹臨床療效觀察. 重慶醫科大學學報, 2013, 38(3): 311-314.
15. 帶狀皰疹后神經痛診療共識編寫專家組. 帶狀皰疹后神經痛診療中國專家共識. 中國疼痛醫學雜志, 2016, 22(3): 161-167.

West China Medical Journal

Study on the quality of life in patients with post-herpetic neuralgia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content